How much do you know about testicular cancer? It’s relatively uncommon, so many individuals aren’t very aware of it. While it’s a daunting diagnosis to receive, there is good news: “Most men with testicular cancer will be cured of it,” said Daniel M. ...
Read MoreMaking the Most of Telehealth Visits
Technology is bringing us closer, especially now that the COVID-19 pandemic is keeping us apart. One example is telehealth visits, which allow patients to remotely connect with their care team and receive world-class care from the comfort of their home. ...
Read MoreMaking the Most of Telehealth Visits
Understanding Lynch Syndrome and the Risk of Cancer
Lynch syndrome is an inherited disorder that increases the risk of many types of cancer, particularly cancers of the colon and uterus. Around 1 in 279 people may carry a mutation in one of the genes associated with Lynch syndrome. Knowing if you or a loved ...
Read MoreUnderstanding Lynch Syndrome and the Risk of Cancer
Prostate Cancer: Common Questions, Answered
Prostate cancer is the most common type of cancer diagnosed in American men, affecting 10 percent of all men during their lifetime. And yet, many screening and treatment questions don’t always have straightforward answers. Recently, Fox Chase Cancer Cent...
Read MoreProstate Cancer: Common Questions, Answered
Young-Onset Colorectal Cancer: A Growing Concern
Colorectal cancer might not be on your radar if you’re in your 30s or 40s—but it should be. One in 10 new cases are diagnosed in individuals under age 50, and rates of young-onset colorectal cancer are on the rise. “Even though the number is still low, w...
Read MoreYoung-Onset Colorectal Cancer: A Growing Concern
Why Second Opinions Matter for Sarcoma
Updated July 15, 2021 Sarcoma is a rare type of cancer - with less than 20,000 new diagnoses occurring each year. Because it is so rare, not all doctors are familiar with how to treat these tumors effectively, which makes it especially important to seek ...
Read MoreWhy Second Opinions Matter for Sarcoma
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this